Works matching IS 26882663 AND DT 2023 AND VI 4 AND IP 3
Results: 48
Issue Information.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.264
- Publication type:
- Article
Diagnosis of acutemyocardial infarction using a combination of circulating circular RNA cZNF292 and clinical information based on machine learning.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.299
- By:
- Publication type:
- Article
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.261
- By:
- Publication type:
- Article
Enhanced nuclear translation is associated with proliferation and progression across multiple cancers.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.248
- By:
- Publication type:
- Article
Timely assessment of 5-year relative survival of esophageal cancer patients in Taizhou, Zhejiang province.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
YAP/TEAD1 and β-catenin/LEF1 synergistically induce estrogen receptor α to promote osteogenic differentiation of bone marrow stromal cells.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.246
- By:
- Publication type:
- Article
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS-CoV-2.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.254
- By:
- Publication type:
- Article
Targeting KAT2A inhibits inflammatory macrophage activation and rheumatoid arthritis through epigenetic andmetabolic reprogramming.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.306
- By:
- Publication type:
- Article
A two-step infection model: From SARS-CoV-2 entry and trafficking to egress and spread.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.295
- By:
- Publication type:
- Article
The epigenetic regulatorymechanisms of ferroptosis and its implications for biological processes and diseases.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.267
- By:
- Publication type:
- Article
Organoids: The current status and biomedical applications.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.274
- By:
- Publication type:
- Article
Antigen-presenting cells maintain T cells proliferation through vesicle transfer of telomeres: A new approach to telomere extension.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.270
- By:
- Publication type:
- Article
Biomaterial-based gene therapy.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.259
- By:
- Publication type:
- Article
SNORA71C promotes development and metastasis of breast cancer by regulating RUNX1 and ferroptosis.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Synergistic augmentation of osimertinib-induced autophagic death by proguanil or rapamycin in bladder cancer.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Nontargeted metabolomics analysis of follicular fluid in patients with endometriosis provides a new direction for the study of oocyte quality.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.302
- By:
- Publication type:
- Article
Clinical significance of soluble programmed cell death-ligand 1 in hepatitis B virus-related hepatocellular carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Mechanistic advances in osteoporosis and anti-osteoporosis therapies.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.244
- By:
- Publication type:
- Article
Modeling cross-talk of RNAmodification enzymes reveals tumor microenvironment-associated clinical significance and immunotherapy prediction in hepatobiliary malignancy.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.256
- By:
- Publication type:
- Article
Themicrobiota-gut-brain axis regulates motivation for exercise.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.304
- By:
- Publication type:
- Article
Exosomes in brain diseases: Pathogenesis and therapeutic targets.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.287
- By:
- Publication type:
- Article
Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.288
- By:
- Publication type:
- Article
Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.269
- By:
- Publication type:
- Article
Optimum fractionation of radiation to combine PD-1 blockade.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.271
- By:
- Publication type:
- Article
Far upstream element-binding protein 1 confers lobaplatin resistance by transcriptionally activating PTGES and facilitating the arachidonic acid metabolic pathway in osteosarcoma.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.257
- By:
- Publication type:
- Article
Advanced therapy medicinal products in China: Regulation and development.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.251
- By:
- Publication type:
- Article
RAS-targeted cancer therapy: Advances in drugging specific mutations.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.285
- By:
- Publication type:
- Article
Post-translational modifications of histones: Mechanisms, biological functions, and therapeutic targets.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.292
- By:
- Publication type:
- Article
Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR-1236/HER2 signaling pathway.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.282
- By:
- Publication type:
- Article
Caffeic acid, but not ferulic acid, inhibits macrophage pyroptosis by directly blocking gasdermin D activation.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.255
- By:
- Publication type:
- Article
Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.293
- By:
- Publication type:
- Article
Optimal transplantation strategy using human induced pluripotent stem cell-derived cardiomyocytes for acute myocardial infarction in nonhuman primates.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.289
- By:
- Publication type:
- Article
Frailty trajectory predicts subsequent cognitive decline: A 26-year population-based longitudinal cohort study.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.296
- By:
- Publication type:
- Article
Earlier second polar body transfer and further mitochondrial carryover removal for potential mitochondrial replacement therapy.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.217
- By:
- Publication type:
- Article
Correction to: Autophagic activation of IRF-1 aggravates hepatic ischemia-reperfusion injury via JNK signaling.
- Published in:
- 2023
- Publication type:
- Correction Notice
A quantitative planar array screen of 440 proteins uncovers novel serum protein biomarkers of idiopathic nephrotic syndrome.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Understanding and targeting resistance mechanisms in cancer.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.265
- By:
- Publication type:
- Article
Relationships between smoking behavior, systemic inflammation, andmyocardial infarction and their effects on long-term outcomes in older Chinese patients with coronary artery disease: A prospective study with a 10-year follow-up.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
TXNL4B regulates radioresistance by controlling the PRP3-mediated alternative splicing of FANCI.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.258
- By:
- Publication type:
- Article
Role of pyroptosis in the pathogenesis and treatment of diseases.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.249
- By:
- Publication type:
- Article
Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.268
- By:
- Publication type:
- Article
A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.263
- By:
- Publication type:
- Article
PROTACs: A novel strategy for cancer drug discovery and development.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.290
- By:
- Publication type:
- Article
Genetic inhibition of glutamate allosteric potentiation of GABAARs in mice results in hyperexcitability, leading to neurobehavioral abnormalities.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.235
- By:
- Publication type:
- Article
Risk and outcomes of breakthrough COVID-19 infections in vaccinated immunocompromised patients: A meta-analysis.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.307
- By:
- Publication type:
- Article
tRNA-derived fragments are promising biomarkers for screening of early colorectal cancer.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.227
- By:
- Publication type:
- Article
Multiomics analysis of human peripheral blood reveals markedmolecular profiling changes caused by one night of sleep deprivation.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.252
- By:
- Publication type:
- Article
Signaling pathways and intervention for therapy of type 2 diabetesmellitus.
- Published in:
- MedComm, 2023, v. 4, n. 3, p. 1, doi. 10.1002/mco2.283
- By:
- Publication type:
- Article